revised 12/07 american college of veterinary radiology

Cornell University 2.15.08

Revised 12/07

AMERICAN COLLEGE OF VETERINARY RADIOLOGY

RECOGNIZED VETERINARY SPECIALTY OF RADIATION ONCOLOGY (ACVR-RO)

RESIDENCY TRAINING PROGRAM RE-ACCREDITATION APPLICATION

NOTE: Some questions in this form are included for data collection purposes. The inclusion of

an item does not necessarily imply that the item is a program requirement for ACVR-RO

residency program. Please refer to the current Radiation Oncology Training Program Guidelines

for comprehensive residency training requirements. This document may be downloaded from

Members Only Downloads section of the ACVR website at http://www.acvr.org.

APPLICATION INSTRUCTIONS:

Training program directors wishing to have their programs evaluated should submit this

electronic form and appropriate attachments electronically to the Chair of the Residency

Standards and Evaluation Committee (RSEC) and to the Assistant Executive Director of the

ACVR. The application must be received by February 15 of the third year following initial

program approval / last re-accreditation The RSEC will evaluate the application, a vote will be

taken, and the results of the vote and the majority recommendation of the committee forwarded

to the President of the Recognized Veterinary Specialty for consideration at Executive Council at

one of the two annual meetings.

For the required ACVR and ACVIM Diplomates providing consultation in medical

oncology and imaging, that are new to the program, please provide a brief 2-page curriculum vitae

and specify the number of weeks each year that the individual will be available to actively support

the radiation oncology resident.

ACVR-RO RESIDENCY STANDARD TRAINING PROGRAM

REACCREDITATION APPLICATION

1. Date of Application

2/15/08

Date of Initial Program Approval

2002


Date of Last Re-accreditation

2. Program Director(s): (Must be a Diplomate of ACVR Recognized Veterinary Specialty

of Radiation Oncology)

Margaret C. McEntee

Program Director’s Contact Information:

Work Phone: 607-253-3208

Fax: 607-253-3055

E-mail: [email protected]

3. Additional ACVR-RO Diplomates supporting the program (not Program Directors)

None

Numbers of weeks per year an ACVR-RO Diplomate is available to resident on a daily basis.

48

4. Do you have a radiation oncology resident in training at this time?

5. Name of resident(s)

1/1/06

Yes No

X


N/A

Is/are the resident(s) in an approved Standard program or an Alternative program:

Standard Alternative

N/A

6. Dates of training program (Please list only those dates of the actual training program. Time spent by the resident at your facility prior to beginning or following the completion of the actual training program should not be included.)

Dates of training program for resident (1) (mm/dd/yy)

N/A

Dates of training program for resident (2) (mm/dd/yy)


7. Location of Primary Institution

Primary Site:

Cornell University, College of Veterinary Medicine

Department

Department of Clinical Sciences

Hospital/University

Cornell University Hospital for Animals

Address

Dept. of Clinical Sciences, CVM, Cornell University

City, State Zip Country

Ithaca, NY 14853 USA

8. Cooperating Institution(s) (If applicable):

Roswell Park Cancer Institute

Department

Radiation Medicine

Hospital/University

Roswell Park Cancer Institute

Address

Elm & Carlton Streets

City, State, Zip, Country

Buffalo, New York 14263 USA

For cooperating institutions, attach letters of agreement signed on behalf of the

institution(s) by appropriate individual(s).

9. Length of Training Program (months):

24

If greater than 2 years, will this period include 24 months of continuous training in


radiation oncology?

10. Number of months dedicated solely to radiation oncology training (excluding time on

Medical Oncology service, Radiology/Imaging, etc.)

18

11. Advanced Degree:

Yes No Optional

Masters: X

PhD: X

12. Essential Program Faculty: individual faculty member may serve in only one capacity

Please list all qualified faculty in support of program

a. Diagnostic Radiologist(s): (Must be Diplomate(s) of the ACVR)

Nathan Dykes, Peter Scrivani, Margret Thompson

Number of weeks per year an ACVR – Radiology diplomate is available to resident on a

daily basis.

50

Faculty member on site?

Yes No

X

If off site, please explain relationship.

Yes No


b. Medical Oncologist(s): (must be Diplomate(s) of ACVIM, Specialty of

Oncology)

Kenneth Rassnick, Dennis Bailey, Rodney Page

Number of weeks per year an ACVIM-Oncology Diplomate is available to resident on a

daily basis.

50


Yes No

X

If off site, please explain relationship

c. Surgeon(s): (must be Diplomate(s) of the ACVS)

H. Jay Harvey, James Flanders, Eric Trotter, Rory Todhunter, Stuart Bliss,

Ursula Krotscheck

Number of weeks per year an ACVS faculty member is available to resident on a daily

basis.

50


Yes No


X


d. Pathologist(s): (must be Diplomate(s) of the ACVP)

Sean McDonough, Donald Schlafer, Gerald Duhamel, Jeanine Peters-Kennedy,

Rachel Mo-Peters, Beth Buckles, Tracy French (clin path), Tracy Stokol (clin

path), Deanna Schaefer (clin path)

Number of weeks per year an ACVP faculty member is available to resident on a daily

basis.

50


Yes No

X


Please list all additional board certified specialists in direct support of the program. If offsite,

please explain relationship.

Name Certifying College / Board

William Horne ACVA


Luis Campoy ACVA

Robin Gleed ACVA

John Ludders ACVA

Andrea Looney ACVA

Sydney Moise ACVIM (cardiology)

Anna Gelzer ACVIM (cardiology)

Marc Kraus ACVIM (cardiology)

Curtis Dewey ACVIM (neurology)

Sofia Cerda-Gonzalez ACVIM (neurology)

Nita Irby ACVO

Thomas Kern ACVO

Eric Ledbetter ACVO

Joseph Wakshlag ACVN

Stephen Barr ACVIM (internal medicine)

Sharon Center ACVIM (internal medicine)

Richard Goldstein ACVIM (internal medicine)

William Hornbuckle ACVIM (internal medicine)

John Randolph ACVIM (internal medicine)

Kenneth Simpson ACVIM (internal medicine)

Nishi Dhupa ACVECC, ACVIM (int. med.)

Daniel Fletcher ACVECC

Gretchen Schoeffler ACVECC

Danny Scott ACVD

William Miller ACVD

James K. Morrisey ABVP (avian)


Jennifer Rawlinson Dentistry

13. How does resident receive training in Medical Oncology? What is time allotted for this

training. Please provide description of formal and informal training experiences?

14. How is resident trained in diagnostic imaging? What is time allotted for this training.

Please provide description of formal and informal training experiences?

One month rotation on the radiology service with responsibility to generate reports on

imaging studies. Routine evaluation and review of all imaging studies performed on

radiation therapy patients, as well as medical oncology patients. Films are routinely

reviewed during the Friday morning rounds and on a daily basis during afternoon

ward rounds.

2 one month rotations through the medical oncology section. On medical oncology

rotation will receive new cases, see rechecks and be involved in the evaluation and

treatment of both medical and radiation oncology cases. Will participate in twice daily

rounds on the oncology service to discuss current cases. Medical and radiation oncology

function as one service at Cornell University and there is daily discussions between the

two specialties and shared responsibility for the patients.


15. How is resident trained in radiation biology? Please provide description of formal and

informal training experiences?

Radiation biology course.

16. How is resident trained in cancer biology? Please provide description of formal and

informal training experiences?

Through topic reviews and journal club articles in Monday morning rounds.

Additionally opportunities arise routinely in the clinical arena during the evaluation,

and management of cancer patients.

17. How is resident trained in radiation oncology physics? Please provide description of

formal and informal training experiences?

Radiation physics course.

18. Please list any formal courses and their instructors included in the residency training

curriculum. Please attach syllabi and instructor credentials for each listed course.

1. Radiation biology course, Margaret McEntee, DACVR(RO)

2. Radiation physics course, Medical physicists from Roswell Park Cancer Institute

(Sanjay Raina, PhD, Asst. Prof., Radiation Oncology Physics)


19. Does the resident participate in clinical rounds on a daily basis while on clinical

rotations? Is a supervising Diplomate available for the majority of rounds? If no, please

describe how rounds are attended and supervised.

Yes No

X

Comments:

20. Are formal conferences, such as clinicopathologic conferences, journal clubs, or seminars

held on a weekly basis?

Yes No

X

Comments:

21. Please provide a description of the conferences, etc., that are provided and the typical

schedule.

1. Journal club – combination of journal club and topic review rounds which are held

every Monday morning 8-9 AM with presentations given by medical and radiation

oncology residents and faculty.

2. Tumor board rounds – combined rounds with pathology, radiology, surgery and

oncology to address different tumor types presented by faculty and/or residents in the

three specialties held once a month on Friday morning from 8-9AM.

3. Morbidity/mortality rounds – held once weekly includes participation of residents and

faculty in oncology to discuss current challenging cases.

4. Neurology and cardiology rounds – optional, held sometimes once weekly.

5. Anesthesia lecture series – topics presented by anesthesia residents and faculty on a

weekly basis.


6. Chart rounds – weekly review of radiation records and port films for current patients.

7. Histopathology rounds – pathology residents and faculty present current surgical

biopsies to clinicians on a daily basis which includes seeing the slides and discussion of

the findings and diagnosis.

8. Radiology rounds – each morning to review cases from the previous day; attended

when possible and when rotating through radiology.


22. Is the resident required to give one or more formal presentations at a conference or in an educational setting on a yearly basis? If yes, please describe these conferences or educational settings.

Yes No

X

Comments: Options include but are not limited to lectures given at Cornell

University to interns/residents/students/faculty, presentations at ACVR,

VCS, or ACVIM annual conferences

23. How many major veterinary medical or medical meetings is each resident able to or

expected to attend during his/her training program? Please list the meetings attended.

None One Two > Two

X

Comments: Options include but are not limited to ACVR annual conference, VCS

meeting, ASTRO

24. Does the training program require a research project? Please indicate the number of

research projects required.

Yes No Optional Number

X 1

Comments:

25. Are one or more publications required as part of the training program?

Yes No Number

X 1

Comments:


26. Please indicate the availability of the following facilities or equipment. Indicate if these are

available at the primary training site, or at a different location. For facilities that are not on-

site, please describe the situation and availability in the space at the end of this section.

Available? On-Site? Equipment / Service

Yes No Yes No

Megavoltage Teletherapy Machine

Please specify manufacturer and model: Siemens Primus 6

MV linac with MLC and 5-14 MeV electrons

X X

3D - Computer based treatment planning system

Please specify manufacturer and model: Philips Pinnacle

X X

2D/2.5 D - Computer based treatment planning system

Please specify manufacturer and model:

X

LDR Brachytherapy treatment and planning X

HDR Brachytherapy treatment and planning X

Diagnostic Radiology / Imaging Services X X

Conventional Radiography X X

Fluoroscopy X X

Ultrasound X X

Nuclear Medicine X X

Computed Tomography X X

Magnetic Resonance Imaging X X

Positron Emission Tomography X

Intensive Care Facility - 24 hours X X


Clinical Pathology capabilities: (includes CBC, serum

chemistries, blood gases, urinalysis, cytology, parasitology,

microbiology,and endocrinology)

X X

Veterinary Library w/Literature Searching Capabilities

X X

Medical Library w/Literature Searching Capabilities

X X

27. If any of the above equipment or facilities are available off-site, please explain how the

resident can access them for case management, research, or study.

Cornell Medical School library materials available electronically

28. Please list numbers of patients treated in the last 12 months using the listed radiation

treatment modalities.

Modality Number Treated

Megavoltage Gamma / X-ray Teletherapy 90

LDR Brachytherapy 0

HDR Brachytherapy 0

Injectable Radionuclide therapy

Radioiodine (through radiology service) 50


Other (please specify) 0

90Strontium Pleisotherapy 8

Other - please specify 0


29. Describe procedures for resident record recording of radiation treatment details of all

patients.

A detailed record is compiled for each radiation patient including: detailed treatment

chart to record daily treatments by field, hand calculations on all computer plans, daily

progress notes, medical history summarized by resident, physical examination

performed by resident, diode measurements recorded, anesthesia record (by

technicians), and record includes copies of blood work, imaging reports, histopathology

reports, etc. A complete paper record is maintained for each patient and each patient is

entered into the computer database.

30. What procedures are in place to facilitate collection of follow up information of patients

treated?

Computer database of radiation patients tracks routine recheck times. If a patient does

not return to Cornell for routine rechecks then phone calls are placed by the radiation

resident, and/or radiation oncology technicians to the owner and/or referring veterinarian

to obtain follow up.

31. By what mechanisms and how often are residents evaluated? Please attach form used in

this evaluation (required).

Residents are evaluated by the 3rd and 4th year veterinary students that rotate through the

oncology service and provided with a summary of the evaluations every 6 months. These

evaluations are done electronically.

Residents are evaluated by the medical and radiation oncology faculty every 6 months

(see attached form) and a formal review of their performance and progress is provided in

a meeting between the resident and the radiation oncology program director.


32. Please list the residents who have completed the training program including the year that

each individual’s training program ended. If at all possible, please provide an address,

and any information you have on the status of each individual with respect to the board

certification process.

John Farrelly completed residency in 2004 and passed the certifying exam in 2004.

Current address is as follows:

Head, Radiation Therapy

The Animal Medical Center

510 East 62nd Street

New York, NY 10021

Blaise Burke completed residency in 2004/2005 and passed the certifying exam in 2005

Current address is as follows

Veterinary Specialty Hospital

10435 Sorrento Valley Road

San Diego, CA 92121

Tracy Gieger completed residency in 2007 and passed the certifying exam in 2007

California Veterinary Specialists (2 locations)

33. Please list any additional information of interest in support of this residency

re-accreditation application.

NYS Diagnostic Laboratory on site

Attachments:

Please attach the following documents to the application if applicable. Please mark box to

indicate which documents are included. Please list any additional documents attached in support

of this application.


Attached? Documents

YES Twenty-four (24) month calendar of resident’s activities - Required

YES CV - ACVR-RO Diplomate - Program Director(s) - Required

YES (new) CV - ACVR-R Diplomate(s) - Required

YES (new) CV - ACVIM-O Diplomate(s) - Required

YES Syllabi of formal course work included in the training program - Required

YES Credentials of instructors providing formal course work - Required

YES Forms used in resident evaluation - Required

YES Letters of agreement from cooperating institutions - Required


Radiation Oncology Residency Calendar

July Aug Sept Oct Nov Dec Jan Feb Mar April May June

MO RO RO RO Rad RO* RO RO RO RO Anes* RO

MO RO RO RO RO RO* RO RO RO RO RO Study

MO – medical oncology (2 months total): Responsible for receiving both medical and radiation oncology patients

that present for evaluation (diagnostics to include blood work, imaging, biopsy, etc.) and therapy, and to see recheck

appointments with an emphasis on the radiation oncology patients that present for rechecks. Participate in twice

daily ward rounds to discuss current patients. Attend and also routinely responsible for morning teaching rounds

with 3rd and 4th year veterinary students that are rotating through the oncology service.

RO – radiation oncology (18 months total): To consult on all potential radiation therapy patients that present to

oncology or present to other services in the hospital. Develop a diagnostic and therapeutic plan. Review all imaging

studies and the medical record for radiation patients. Perform a physical examination on all radiation patients prior

to initiation of a course of radiation therapy. Position patients (vac-lok) for CT imaging for radiation treatment

planning. Radiation treatment planning both CT based computer assisted 3D radiation treatment planning and

manual planning. Involved in the daily treatment of radiation patients including assisting with anesthesia, patient

positioning and delivery of radiation therapy. Telephone consultations with referring veterinarians on potential

radiation patients.

Rad – radiology (1 month total): To attend daily radiology rounds, observe image acquisition, and image

interpretation under the guidance of the radiology residents and faculty. To generate imaging reports to be reviewed

by the radiology faculty.

Anes – anesthesia (2 weeks total): Anesthetize small animal patients under the direction of the anesthesia service.

Participate in the daily anesthesia rounds while on the anesthesia service. Also, to attend anesthesia lecture series

when possible and for relevant topics on anesthetics and management of patients under anesthesia.

Study – (1 month total): To be spent preparing for the radiation oncology certifying examination.

* For each of these one month blocks half of the time is to be spent on the designated service and the other two

weeks are for vacation (10 days total each year) and two weeks optional for work on a project or time on another

service such as pathology or clinical pathology.


CURRICULUM VITAE

MARGARET COLLEEN MCENTEE

Dept. of Clinical Sciences H (607)257-4197 College of Veterinary Medicine W (607)253-3208 Cornell University Fax (607)253-3055

Ithaca, New York 14853 e-mail [email protected]

EDUCATION/PROFESSIONAL POSITIONS

Cornell University

Associate Professor, Oncology – July 31, 2000 - present. Oncology Section Chief - July 1, 2002 – present. Co-Director, Sprecher Institute for Comparative Cancer Research: December 2005 –

present. University of California Davis

Assistant Clinical Professor in Radiation Oncology - May 1997 – May 2000

Oncology Section Chief - October 1, 1999 – May 2000. The Animal Medical Center

New York City, NY

Staff Oncologist (medical and radiation oncology), August 1994 - April 1997. Santa Cruz Veterinary Hospital and Veterinary Tumor Institute

Santa Cruz, CA

Staff Medical Oncologist, October 1993 - August 1994. North Carolina State University

Clinical Instructor, Oncology Service, July 1989 - June 1993.

Medical Oncology - July 1989 - June 1991. Radiation and Medical Oncology - July 1991 - June 1993.

Radiation Oncology Residency (non-conforming) - July 1991 - June 1993.

Resident in Medical Oncology, July 1987 - June 1989. Rotating Internship in Small Animal Medicine and Surgery, July 1986 - June 1987.

Cornell University

College of Veterinary Medicine, Ithaca, NY DVM, Class of 1986.

University of Vermont

Burlington, VT BA in Mathematics and Zoology, Class of 1978.

SPECIALTY BOARD CERTIFICATION

ACVIM, Medical Oncology certifying examination - May 1993. ACVR, Radiation Oncology certifying examination - August 1994.

AWARDS AND RECOGNITION

AAHA Senior Student Award (clinical proficiency in small animal medicine and surgery,


1986). Jacob Traub Award (microbiology, 1986). Phi Beta Kappa (University of Vermont, 1978).

President, American College of Veterinary Radiology, Radiation Oncology Affiliate 2000-2002

PROFESSIONAL SOCIETY MEMBERSHIPS

American College of Veterinary Internal Medicine American Veterinary Medical Association American College of Veterinary Radiology

VRTOG American Society for Therapeutic Radiology and Oncology; active member 7/1/99 American Society of Clinical Oncology; active/allied member 12/29/03

Veterinary Cancer Society Phi Beta Kappa Society New York State Veterinary Medical Society

Southern Tier Veterinary Medical Association CURRENT STATE LICENSURE

California New York State

EDITORIAL REVIEW BOARD

Journal of the American Animal Hospital Association, review board member 1/05 to 10/07 Dog Watch – Advisory Board member 12/05 to present

Cat Watch – Advisory Board member 12/05 to present JOURNAL AD HOC REVIEWER

Veterinary Radiology & Ultrasound Journal of Veterinary Internal Medicine Journal of the American Animal Hospital Association

Journal of the American Veterinary Medical Association Radiation Research Veterinary and Comparative Oncology

Veterinary Clinical Pathology Veterinary Medicine Veterinary Surgery

Journal of Feline Medicine and Surgery American Journal of Veterinary Research

TEACHING/SERVICE RESPONSIBILITIES

Cornell University, College of Veterinary Medicine – 2000-present

Course Participant: Clinical Oncology – Block VI.

Clinical Veterinary Oncology (previously VM 666 elective; currently required

Block V course) – shared lecture responsibilities. Advanced Oncology Distribution course (VM 752) – offered starting Spring

2006.


Block VII a and b – assist with physical examination laboratories for first year veterinary students.

Block II – lecture on cancer therapy.

University of California, Veterinary Medical Teaching Hospital: Radiation Oncology

Service; Service Chief for combined medical and radiation oncology service (October

1999 – May 2000). The Animal Medical Center: Clinical position including medical oncology, radiation oncology

(50% responsibility), involvement in small animal intern and medical oncology residency training programs, lectures.

North Carolina State University: July 1991 to June 1993 - Medical oncology service 3 months/year; Radiation oncology service 12 months/year. July 1989 to June 1991 Coordinator for the clinical oncology service.

RESIDENT TRAINING

The Animal Medical Center

Kenneth Rassnick, medical oncology, 1994-1996 Currently: Assist. Professor of Oncology at Cornell University Timothy Rocha, medical oncology, 1995-1997

Currently: oncology referral practice in NYC Joanne McKnight, medical oncology, 1996-1997 Currently: oncology referral practice in NYC

University of California, Davis School of Veterinary Medicine

Courtney Zwahlen, medical oncology, 1997-1998

Currently: oncology referral practice in California Cecile Siedlecki, medical oncology, 1997-1999 Currently: oncology referral practice in California

Michael Kent, medical oncology, 1999-2000 Currently: Assist. Professor of Oncology at the University of California, Davis Tracy Gieger, medical oncology, 1999-2000

Cornell University, College of Veterinary Medicine

Medical Oncology Residents

Dennis Bailey, medical oncology, 2001-2004 Board certified, 2004 Currently: Lecturer, Cornell University, CVM

Andrea Flory, medical oncology, 2004-2007 Board certified, 2007 Currently: Staff oncologist, Animal Medical Center, NYC

Cheryl Balkman, medical oncology, 2003-2007 Passed medical oncology certifying examination 2007 Currently: Lecturer, Oncology, Cornell University

Michael Kiselow, medical oncology, 2005-2008 Joanne Intile, medical oncology, 2006-2009 Sandra Barnard, medical oncology 2007-2010


Radiation Oncology Residents John Farrelly, radiation oncology, 2001-2004

Board certified, 2004 Currently: staff radiation oncologist at the Animal Medical Center, NYC Blaise Burke, radiation oncology, 2002-2005

Board certified, 2005 Currently: oncology referral practice, San Diego CA Rodney Page, radiation oncology, 2003-2007 (early termination of training program

September 1, 2005) Currently: Department Chair, Clinical Sciences, Cornell University Tracy Gieger, radiation oncology, 2005-2007

Board certified, 2007 Currently: oncology referral practice, San Diego CA

GRADUATE STUDENT TRAINING

Michael Lucroy PhD qualifying examination committee; University of California, Davis, January 1999. Converted to a Masters Program.

RESEARCH FUNDING (associated abstracts and manuscripts resulting for funded research

listed below). CURRENT

1) In vitro characterization of docetaxel as a radiosensitizer in canine cancer cell lines. Dean’s Fund for Clinical Excellence. PI – Margaret McEntee. $ 7,720. Submitted September 1,

2005. Funded $7,720. Extension through December 2007.

Abstract #: N/A Manuscript #: 47 - in preparation.

2) Use of implanted gold fiducial markers to aid in patient re-positioning for radiation therapy

in dogs. 2007 Dean’s Fund for Clinical Excellence. PI – Margaret McEntee, Co-

investigators – Tracy Gieger, Michele Steffey, Margret Thompson. $ 6,375. Submitted January 8, 2007. Funded, effective April 15, 2007 (one year grant).

Abstract #: N/A Manuscript #: N/A 3) Accuracy of T1 and T2 MRI signal intensities for the diagnosis of melanoma in dogs with

an oral tumor. PI – P Scrivani, M McEntee – Co-Inv. Dean’s Fund for Clinical Excellence. $7,000. Initiated April, 2007.

Abstract #: N/A Manuscript #: N/A 4) Phase II study of oral docetaxel and cyclosporine in feline epithelial cancer. Morris Animal

Foundation. PI – Margaret McEntee, Co-investigator – Kenneth Rassnick. 2-year study, $79,776. Pre-proposal submitted November 1, 2006. Funded for $80,188 (year 1 $39,339, year 2 $40,849). Start date November 1, 2007.


Abstract #: N/A Manuscript #: N/A

PENDING None

COMPLETED

1) The utility of contrast-enhanced computed tomography in the evaluation and treatment of

cats with vaccine associated fibrosarcomas. Submitted to Vaccine-Associated Feline Sarcoma Task Force. 1999-2000. $28,905.00. Funded. PI - Margaret McEntee, Co-PI - Valerie Samii.

Abstract #: 26 Manuscript #: pending

2) Phase I/II study of oral docetaxel and cyclosporine in canine cancer. Morris Animal Foundation. Pre-proposal submitted November 1, 2001. $113,191. PI – Margaret McEntee, Co-PI’s – Rodney Page, Kenneth Rassnick, Jeffrey Silverman. Pre-proposal

approved and proposal submitted April 1, 2002. Submitted Phase I study of oral docetaxel and cyclosporine in canine cancer. $48,445. Funded (start date of September 1, 2002). PI – Margaret McEntee. Co-PI’s – Rodney Page, Kenneth Rassnick.

Abstract #: 40 Manuscript #: 39

3) Pre-operative versus post-operative 3-D radiation treatment planning for feline fibrosarcomas: a pilot study. Dean’s Fund for Clinical Excellence. 2002-2003. $9,630. PI – Margaret McEntee, Co-PI’s – Anthony Pease, Nathan Dykes, Hollis Erb. Funded (start

date July 1, 2002).

Abstract #: 41 Manuscript #: in preparation

4) Phase I study of docetaxel in feline cancer. Cornell Feline Health Center Research Grant

Program. PI – Margaret McEntee, Co-PI’s – Rodney Page, Kenneth Rassnick. Submitted December 2002. Funded $18,650.

Abstract #: Manuscript #: 41 5) Optimization of spermatogonial stem cell transplantation in the domestic cat. Cornell

Feline Health Center Research Grant Program. PI – Alexander Travis, Co-PI – Margaret McEntee. Submitted August 2003. Funded $ 20,000.

Abstract #: Manuscript #: 38 6) Pharmacokinetic analysis of docetaxel disposition after oral administration in tumor-bearing

cats. Cornell Feline Health Center Research Grant. PI – Margaret McEntee. $10,656. Submitted April 6, 2005. Funded $ 9,590 (note: all grants funded at a 10% across the board cut).


Abstract #: Manuscript #: 41

7) Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer. Morris

Animal Foundation. Pre-proposal submitted November 1, 2003. $152,093. PI – Margaret

McEntee, Co-PI’s – Rodney Page, Kenneth Rassnick. Full proposal requested, submitted 3/31/04. Funded $152,503. (Year 1 [2004-2005] - $74,820; Year 2 [2005-2006] - $77,683).

Abstract #: Manuscript #: in preparation

PUBLICATIONS

REFEREED ARTICLES

1) Page RL, Stiff ME, McEntee MC, Walter LG. Transient glomerulonephropathy associated with primary erythrocytosis in a dog. Journal of American Veterinary Medical

Association 196(4):620-622, 1990. 2) McEntee MC, Page RL, Heidner GL, Cline JM, Thrall DE. A retrospective study of 27

dogs with intranasal neoplasms treated with cobalt radiation. Veterinary Radiology

32(3):135-139, 1991. 3) Heidner GL, Page RL, McEntee MC, et al. Treatment of canine appendicular

osteosarcoma using cobalt 60 radiation and intraarterial cisplatin. Journal of Veterinary

Internal Medicine 5:313-316, 1991. 4) Page RL, Thrall DE, Dewhirst MW, Macy DW, George SL, McEntee MC, et al. Phase I

study of melphalan alone and melphalan plus whole body hyperthermia in dogs with

malignant melanoma. International Journal of Hyperthermia 7(4):559-566, 1991. 5) McEntee MC, Page RL, Cline JM, Thrall DE. Radiation pneumonitis in three dogs.

Veterinary Radiology & Ultrasound 33(4):190-197, 1992.

6) Novotney CA, Page RL, Macy DW, Dewhirst MW, Ogilvie GK, Withrow SJ, McEntee

MC, et al. Phase I evaluation of doxorubicin and whole body hyperthermia in dogs with lymphosarcoma. Journal of Veterinary Internal Medicine 6:245-249, 1992.

7) Page RL, Thrall DE, George SL, Price GS, Heidner GL, McEntee MC, et al. Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs. International Journal of

Hyperthermia 8(6):761-769, 1992. 8) Page RL, Macy DW, Ogilvie GK, Rosner G, Dewhirst MW, Thrall DE, Withrow SJ,

McEntee MC, et al. Phase III evaluation of doxorubicin and whole body hyperthermia

in dogs with lymphoma. International Journal of Hyperthermia 8(2): 187-197, 1992. 9) Forrest LJ, Dodge RK, Page RL, Heidner GL, McEntee MC, et al. Relationship between

quantitative tumor scintigraphy and time to metastasis in dogs with osteosarcoma. The

Journal of Nuclear Medicine 33(8):1542-1547, 1992. 10) McEntee MC, Page RL, Novotney CA, Thrall DE. Palliative radiotherapy in the

management of canine appendicular osteosarcoma. Veterinary Radiology & Ultrasound

34(5):367-370, 1993. 11) Page RL, McEntee MC, George SL, et al. Pharmacokinetic and phase I evaluation of

carboplatin in dogs. Journal of Veterinary Internal Medicine 7:235-240, 1993.


12) Thrall DE, McEntee MC, Novotney C, Hauck ML, Page RL. A boost technique for irradiation of malignant canine nasal tumors. Veterinary Radiology & Ultrasound 34(4):295-300, 1993.

13) Thrall DE, Heidner GL, Novotney CA, McEntee MC, Page RL. Failure patterns following cobalt irradiation in dogs with nasal carcinoma. Veterinary Radiology & Ultrasound 34(2):126-133, 1993.

14) Vail DM, Powers BE, Getzy D, Morrison WB, McEntee MC, et al. Factors influencing prognosis of 36 dogs with synovial sarcoma: A veterinary cooperative oncology group (VCOG) study. Journal of American Veterinary Medical Association 205(9):1300-,

1994. 15) Thrall DE, McEntee MC, Cline JM, Raleigh JA. ELISA quantification of CCI-103F

binding in canine tumors prior to and during irradiation. International Journal of

Radiation Oncology Biology and Physics 28(3):649-659, 1994. 16) Page RL, McEntee MC, Williams PL, et al. Effect of whole body hyperthermia on

carboplatin disposition and toxicity in dogs. International Journal of Hyperthermia

10(6):807-816, 1994. 17) McEntee MC, Thrall DE. Use of portal radiography to increase accuracy of dose

delivery in radiation therapy. Veterinary Radiology & Ultrasound 36(1): 69-77, 1995.

18) Raleigh JA, Zeman EM, Calkins DP, McEntee MC, Thrall DE. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. Acta Oncologica 34(3):345-349, 1995.

19) London CA, Dubilzeig RR, Vail DM, Ogilvie GK, Hahn KA, Brewer WG, Hammer AS, O’Keefe DA, Chun R, McEntee MC, et al. Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978-1992). Journal of American Veterinary Medical

Association 208(9):1413-1418, 1996. 20) Thrall DE, Rosner GL, Azuma C, McEntee MC, Raleigh JA. Hypoxia marker labeling

in tumor biopsies: quantification of labeling variation and criteria for biopsy selection.

Radiotherapy & Oncology 44(2):171-176, 1997. 21) Thrall DE, LaRue SM, Powers BE, Page RL, Johnson J, George SL, Kornegay JN,

McEntee MC, Dewhirst MW, Gillette EL. Use of whole body hyperthermia as a method

to heat inaccessible tumors: A phase III trial in canine brain masses. International Journal of Hyperthermia 15(5):383-398, 1999.

22) Gieger T, McEntee MC. What is your diagnosis ? Soft tissue sarcoma in a fourteen

year old domestic shorthair cat. Journal of American Veterinary Medical Association 214:1155-1156, 1999.

23) Rassnick KM, Mauldin GN, Moroff SD, Mauldin GE, McEntee MC, Mooney SC.

Prognostic value of argyrophilic nucleolar organizer region (AgNOR) staining in feline intestinal lymphoma. Journal of Veterinary Internal Medicine 13:187-190, 1999.

24) McEntee MC, Page RL, Mauldin GN, Thrall DE. Infiltrative lipoma: results of

irradiation in 13 dogs. Veterinary Radiology & Ultrasound 41(6):554-556, 2000. 25) McKnight JA, Mauldin GN, McEntee MC, Meleo KA, Patnaik AK. Radiation therapy

for incompletely resected soft tissue sarcomas in dogs: 48 cases (1988-1996). Journal of

American Veterinary Medical Association 217:205-210, 2000. 26) McEntee MC, Thrall DE. Computed tomographic appearance of infiltrative lipomas in

22 dogs. Veterinary Radiology & Ultrasound 42(3):221-225, 2001.

27) McEntee MC, Page RL. Feline vaccine associated sarcomas. Journal of Veterinary Internal Medicine 15:176-182, 2001.


28) Dickinson PJ, McEntee MC, Sturges BK, Lipsitz D, LeCouteur RA. Radiation induced vertebral osteosarcoma following treatment of an intradural extramedullary spinal cord tumor in a dog. Veterinary Radiology & Ultrasound 42(5):463-470, 2001.

29) Slovis NM, McEntee MC, Fairley RA, Galuppo LD, Théon AP. Equine basal cell tumors: six cases (1985-1999). Journal of Veterinary Internal Medicine 15(1):43-46, 2001.

30) Madewell BR, Griffey SM, McEntee MC, Munn RJ. Feline vaccine-associated sarcoma: an ultrastructural study of 20 tumors (1996-1999). Veterinary Pathology 38(2):196-202, 2001.

31) Gieger TL, Theon AP, Werner J, McEntee MC, et al. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). Journal Veterinary Internal Medicine 17(5):687-692, 2003.

32) Henry CJ, Tyler JW, McEntee MC, et al. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. American Journal Veterinary Research 64(8):1017-1020, 2003.

33) McEntee MC, Silverman JA, Rassnick K, Zgola M, Chan AO, Tau PT, Page RL. Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats. Veterinary Comparative Oncology 1(2):105-112, 2003.

34) McEntee MC, Samii VF, Walsh P, Hornof WJ. Postoperative assessment of surgical clip position in 16 dogs with cancer: a pilot study. Journal American Animal Hospital Association 40:300-308, 2004.

35) McEntee MC, Page RL, Theon AP, Erb HN, Thrall DE. Malignant tumor formation in dogs previously irradiated for acanthomatous epulis. Veterinary Radiology & Ultrasound 45(4):357-361, 2004.

36) McEntee MC. A survey of veterinary radiation therapy facilities in the United States during 2001. Veterinary Radiology & Ultrasound 45(5):476-479, 2004.

37) Morrisey JK, McEntee MC. Therapeutic options for thymoma in the rabbit. Seminars

in Avian and Exotic Pet Medicine 14(3):175-181, 2005. 38) Kim Y, Selvaraj V, Dobrinski I, Lee H, McEntee MC, Travis AJ. Recipient preparation

and mixed germ cell isolation for spermatogonial stem cell transplantation in domestic

cats. Journal of Andrology 27(2):248-256, 2006. 39) MC McEntee, Rassnick KM, Lewis LD, Zgola MM, Beaulieu BB, Balkman CE, Page

RL. Phase I and pharmacokinetic evaluation of oral docetaxel and cyclosporin A in

tumor-bearing dogs. American Journal Veterinary Research 67(6):1057-1062, 2006. 40) Turrel JM, Farrelly J, Page RL, McEntee MC. Strontium-90 irradiation for feline

cutaneous mast cell tumors: a retrospective study of 35 cats (1992-2002). Journal

American Veterinary Medical Association 228(6):898-901, 2006. 41) MC McEntee, Rassnick KM, Bailey DB, Balkman CE, Flanagan JL, Beaulieu BB, Zgola

MM, Lewis LD, Page RL. Phase I and pharmacokinetic evaluation of the combination of

orally administered docetaxel and cyclosporin A in tumor-bearing cats. Journal Veterinary Internal Medicine 20(6):1370-1375, 2006.

42) MC McEntee. Veterinary radiation therapy: review and current state of the art. Journal

American Animal Hospital Association 42:94-109, 2006 (invited review). 43) Turrel JM, McEntee MC, Burke BP, Page RL. 131I treatment for advanced thyroid

tumors: a retrospective study of 39 dogs (1990-2003). Journal American Veterinary

Medical Association 229(4):542-548, 2006.


44) Rassnick KM, McEntee MC, Erb HN, Burke BP, Balkman CE, Flory AB, Kiselow MA, Autio K, Gieger TL. Comparison of three protocols following induction of remission in dogs with lymphoma. Journal Veterinary Internal Medicine 21(6):1364-1373, 2007.

45) McEntee MC. Portal radiography in veterinary radiation oncology: options and considerations. Veterinary Radiology & Ultrasound 2008;49(1) Suppl 1:S57-S61.

46) McEntee MC, Steffey M, Dykes NL. Potential utility of surgical hemoclips in radiation

treatment planning. Veterinary Radiology & Ultrasound, in press 2007. 47) McEntee MC, Balkman CE, Gieger TL, Zgola MM, Lewis L. In vitro characterization

of docetaxel as a radiosensitizer in 5 canine and 1 feline cancer cell lines, in preparation,

2007. RESEARCH ABSTRACTS AND PRESENTATIONS

1) Comparison of cisplatin and carboplatin pharmacokinetics at normal and elevated

temperatures in dogs. RL Page, JE Riviere, GL Heidner, MC McEntee, DE Thrall. 5th

International Symposium of Hyperthermia Oncology, Kyoto Japan, August 1988. 2) Phase I evaluation of carboplatin at 37 and 42 degrees c in tumor-bearing dogs. RL Page,

MC McEntee, GL Heidner, JE Riviere, DE Thrall. North American Hyperthermia Group

Meeting, March 1989. 3) Immunophenotypic characterization of canine CLL. CA Novotney, DH Gebhard, RL Page,

MC McEntee, CB Grindem. Veterinary Cancer Society 10th Annual Conference,

November, 1990. 4) Palliative radiotherapy in canine osteosarcoma. MC McEntee, Page RL, Novotney CA,

Thrall DE. Veterinary Cancer Society 10th Annual Conference, November, 1990.

5) Toxicity, pharmacokinetics and efficacy of mitoxantrone administered as a 1-hour infusion in dogs with lymphoma. ML Hauck, CA Novotney, MC McEntee, et al. Veterinary Cancer Society 11th Annual Conference, November 1991.

6) Quantification of 2-nitroimidazole hypoxia marker (CCI-103F) binding in spontaneous canine tumors prior to and during fractionated irradiation. DE Thrall, JM Cline, MC

McEntee, RL Page, JA Raleigh. American Society Therapeutic Radiology Oncology

meeting, November 1992. 7) Effect of administered dose of a 2-nitroimidazole marker of hypoxia on ELISA and

immunohistochemical quantification of tumor binding. MC McEntee, JA Raleigh, DE

Thrall. 41st Annual Meeting of the Radiation Research Society, March 1993. 8) Phase I evaluation of mitoxantrone alone or combined with whole body hyperthermia in

dogs with lymphoma. RL Page, ML Hauck, GS Price, CA Novotney, MC McEntee, DE

Thrall. 13th Annual Meeting of the North American Hyperthermia Society, March 1993. 9) Palliative radiotherapy: indications, complications and preliminary results in dogs and cats

with cancer. KL Cronin, RL Page, MC McEntee, GS Price, et al. Veterinary Cancer

Society 13th Annual Conference, October 1993. 10) Ear canal tumors of dogs and cats: preliminary results of a VCOG retrospective study. CA

London, RR Dubielzig, GK Ogilvie, KA Hahn, WG Brewer, DM Vail, AS Hammer, DA

O’Keefe, R Chun, M McEntee, et al. Veterinary Cancer Society 13th Annual Conference, October 1993.

11) Intravenous melphalan: Phase II evaluation in dogs with malignant melanoma. DM

Ruslander, GS Price, MC McEntee, KL Cronin, CA Novotney, SD Forrester, DE Thrall, RL Page. Veterinary Cancer Society 13th Annual Conference, October 1993.


12) Therapeutic monitoring of lymphoproliferative disorders using monoclonal antibodies to canine leukocytes. RL Page, CA Novotney, DH Gebhard, CA Grindem, EB Breitschwerdt, DM Ruslander, GS Price, KL Cronin, MC McEntee. Veterinary Cancer Society 13th Annual

Conference, October 1993. 13) Infiltrative lipoma: results of irradiation in 9 dogs. MC McEntee, RL Page, GN Mauldin,

KA Meleo, CA Novotney, DE Thrall. Veterinary Cancer Society 14th Annual Conference,

October 1994. 14) Three-dimensional treatment planning in veterinary radiation oncology. MC McEntee, GN

Mauldin. Veterinary Cancer Society 16th Annual Conference, October 1996.

15) Tumor hypoxia in dogs. D Thrall, JM Cline, MC McEntee, C Azuma, JA Raleigh. American College of Veterinary Radiology 1996 Annual Meeting, Chicago, Il, December 1996.

16) Radiation therapy for incompletely resected soft tissue sarcomas in dogs: 48 cases (1988-1996). JA McKnight, N Mauldin, MC McEntee, KA Meleo, A Patnaik. Veterinary Cancer Society 18th Annual Conference, October 1998.

17) Contrast-enhanced computed tomography for treatment planning of feline vaccine-associated sarcomas; preliminary findings. MC McEntee, VF Samii, BR Madewell. Cancer Research Symposium; UCD Medical Center, September 15-16, 1999.

18) Contrast-enhanced computed tomography for treatment planning of feline vaccine-associated sarcomas; preliminary findings. MC McEntee, VF Samii, BR Madewell. Veterinary Cancer Society 19th Annual Conference, November 13-16, 1999.

19) Hemoclip position and utility in radiation treatment planning. A pilot study. MC

McEntee, VF Samii, PJ Walsh, WJ Hornof. Annual Scientific Conference; American College of Veterinary Radiology, December 1-5, 1999.

20) Computed tomography of infiltrative lipomas in the dog: imaging results and utility in radiation treatment planning. MC McEntee, DE Thrall. Annual Scientific Conference; American College of Veterinary Radiology, December 1-5, 1999.

21) The utility of imaging and initial diagnostics in treatment planning. Feline Vaccine Associated Sarcoma Workshop. Annual Conference, American College of Veterinary Radiology, December 1-5, 1999.

22) Strontium-90 in the treatment of cutaneous mast cell tumors. MC McEntee, E Simonson. Veterinary Cancer Society 2nd Annual Mid-Year Conference, Tucson, April 1, 2000.

23) Facial cutaneous mast cell tumors in dogs: a retrospective study of 17 cases (1990-1999). T

Gieger, MC McEntee, S Kraegel, B Madewell. Veterinary Cancer Society 2nd Annual Mid-Year Conference, Tucson, March 31, 2000.

24) The response of canine mast cell tumors to palliative radiation therapy. E Boshoven, M

McEntee, S Siegel. Veterinary Cancer Society 2nd Annual Mid-Year Conference, Tucson, March 31, 2000.

25) Feline vaccine-associated sarcoma: an ultrastructural study of 20 tumors (1996-1999). BR

Madewell, SM Griffey, MC McEntee, RJ Munn. Fourth World Congress of Veterinary Dermatology, August/September 2000, San Francisco, California.

26) The utility of contrast enhanced computed tomography in feline vaccine associated

sarcomas : 35 cases. MC McEntee, VF Samii. 2000 Annual Scientific Conference of the American College of Veterinary Radiology, December 2, 2000.

27) Radiation induced second tumor in dogs irradiated for oral acanthomatous epulis. MC

McEntee, RL Page, AP Theon, DE Thrall. 2001 Annual Scientific Conference of the American College of Veterinary Radiology, August 5-10, 2001.


28) Atlantic Coast Veterinary Conference, Atlantic City, New Jersey, October 9-11th, 2001. Seven hours of continuing education lectures given on a variety of oncology topics (radiation, vaccine associated sarcomas, nasal tumors, mast cell tumors, tumor imaging,

evaluation of superficial masses, diagnostic evaluation of cancer patients). 29) Enhanced bioavailability of oral docetaxel (DT) by cyclosporine A (CsA) in rats and dogs.

Rodney L Page, Jeffrey Silverman, Margaret McEntee, Kenneth Rassnick, Amy Chan,

Paulina Tran-Tau. American Association Cancer Research 93rd Annual Meeting April 6-10, 2002, San Francisco, California.

30) Evaluation of the V-BTA urine test for detection of canine transitional cell carcinoma. CJ

Henry, JW Tyler, MC McEntee, T Stokol, KS Rogers, R Chun, LC Garrett, DL McCaw, ML Higginbotham. American College of Veterinary Internal Medicine 20th Annual Veterinary Medical Forum, Dallas, Texas, May 2002.

31) Veterinary radiation oncology I: current state of the art. MC McEntee 139th American Veterinary Medical Association Convention, July 13, 2002.

32) Veterinary radiation oncology II: definitive vs palliative radiation – decision making

process. MC McEntee 139th American Veterinary Medical Association Convention, July 13, 2002.

33) Tumor staging: now that we found something what do we do about it? MC McEntee 139th

American Veterinary Medical Association Convention, July 13, 2002. 34) Soft tissue sarcomas: an overview. MC McEntee 139th American Veterinary Medical

Association Convention, July 13, 2002.

35) Radiation therapy: what you need to know. MC McEntee. 96th Annual Cornell Veterinary Conference, March 26, 2004.

36) Mast Cell Tumors in Dogs and Cats: Now and in the Future. MC McEntee. 141st AVMA

Annual Convention July 25, 2004. 37) Radiation Therapy: What You and Your Clients Need to Know and What Your

Expectations Should Be. MC McEntee. 141st American Veterinary Medical Association

Annual Convention July 25, 2004. 38) 131-I therapy for advanced, unresectable thyroid tumors in dogs. J Turrel, B Burke, S

Ullman, M McEntee, R Page. 24th Annual Conference of the Veterinary Cancer Society,

Kansas City, Missouri, Nov 3-6, 2004. 39) Pharmacokinetic and phase I study of oral docetaxel and cyclosporine in canine and feline

cancer. M McEntee, K Rassnick, L Lewis, C Balkman, D Bailey, B Beaulieu, M Zgola, R

Page. 25th Annual Conference of the Veterinary Cancer Society, Oct 20-23, 2005, Huntington Beach, CA, p 47.

40) Docetaxel & cyclosporine combination therapy for canine tumors. MC McEntee American

College Veterinary Internal Medicine Forum, Louisville Kentucky, June 2, 2006. 41) Preoperative versus postoperative 3D radiation treatment planning for soft tissue tumors.

MC McEntee, AP Pease, HN Erb, NL Dykes. International Veterinary Radiology

Association/American College Veterinary Radiology Conference, Vancouver, Canada, August 10, 2006.

42) Anti-HLA-DR antibody therapy for treatment of canine b-cell lymphoma; preliminary

clinical evaluation. CE Balkman, R Stein, K Rassnick, M McEntee, D Goldberg, R Page. Genes, Dogs, and Cancer: 4th International Canine Cancer Conference, September 14 - 17th, 2006 Chicago, IL.

43) Half-body radiation therapy versus chemotherapy consolidation following induction chemotherapy for treatment of canine lymphoma. KM Rassnick, MC McEntee, HN Erb,


BP Burke, CE Balkman, AB Flory, MA Kiselow, K Autio. 26th Annual Conference of the Veterinary Cancer Society. October, 2006.

BOOK CHAPTERS

1) Nasal cavity and sinuses. NJ Sharp, MC McEntee, S Gilson, DE Thrall. Problems with

Head and Neck Surgery edited by N Brown and W Kay, JB Lippincott, 1991. 2) Diseases of the spleen. MC McEntee, RL Page. Saunders Manual of Small Animal

Practice edited by SJ Birchard and RG Sherding, WB Saunders, 1994.

3) Principles of adjunct radiotherapy and chemotherapy. MC McEntee. Veterinary Clinics of North America: Small Animal Practice 25(1):133-148, 1995.

4) Radiation therapy in the management of bone tumors. MC McEntee. Veterinary Clinics

of North America: Small Animal Practice 27(1):131-138, 1997. 5) Summary of results of cancer treatment with radiation therapy. MC McEntee. Cancer in

Dogs and Cats, Medical and Surgical Management, edited by W Morrison, Lea &

Febiger, 1998. 6) Radiation therapy: Systems of application and eligible patients. MC McEntee. Current

Veterinary Therapy XIII, Saunders. Edited by JD Bonagura, 2000.

7) Diseases of the spleen. MC McEntee, RL Page. Saunders Manual of Small Animal Practice edited by SJ Birchard and RG Sherding, WB Saunders, 2nd Edition, January 2000.

8) Summary of results of cancer treatment with radiation therapy. MC McEntee. Cancer in Dogs and Cats, Medical and Surgical Management, edited by W Morrison, Teton New Media, 2002.

9) Neoplasms of the nasal cavity. MC McEntee. Textbook of Respiratory Disease in Dogs and Cats edited by Lesley King. WB Saunders, pp 293-301, 2004.

10) Soft tissue sarcomas. RL Page, MC McEntee. Textbook of Veterinary Internal

Medicine 6th Edition, edited by SJ Ettinger and EC Feldman, Elsevier Saunders, pp 752-757, 2005.

11) Vaccine associated sarcomas in cats. Client information sheet. MC McEntee. Textbook

of Veterinary Internal Medicine 6th Edition, edited by SJ Ettinger and EC Feldman, Elsevier Saunders, 2005.

12) Diseases of the spleen. WC Kisseberth, MC McEntee. Saunders Manual of Small

Animal Practice edited by SJ Birchard and RG Sherding, 3rd Edition, 2006. 13) Clinical behavior of non-odontogenic tumors. MC McEntee. Oral and Maxillofacial

Surgery in Dogs and Cats, edited by FJM Verstraete, Elsevier Science, in press 2008.

14) Soft tissue sarcomas. MC McEntee. Textbook of Veterinary Internal Medicine 7th Edition, edited by SJ Ettinger and EC Feldman, Elsevier Saunders, in preparation, due July 2008 for publication in 2010.

NON-REFEREED PUBLICATIONS

1) Effect of radiation and chemotherapy on wound healing. MC McEntee, RL Page. Veterinary Cancer Society Newsletter 12(4):4-5, 1988. Also published in Feline Health Topics for Veterinarians 4(2):1-3, 1989.

2) Ear canal tumors of dogs and cats: preliminary results of a VCOG retrospective study. CA London, RR Dubielzig, GK Ogilvie, KA Hahn, WG Brewer, DM Vail, AS Hammer, DA O’Keefe, R Chun, M McEntee, et al. Veterinary Cancer Society Newsletter, Spring


1993. 3) Hypoxia in canine tumors. DE Thrall, JM Cline, MC McEntee, C Azuma, JA Raleigh.

Veterinary Cancer Society Newsletter Fall 1996.

4) Utility of contrast enhanced computed tomographic imaging of soft tissue sarcomas: Overview and case presentations. VF Samii, MC McEntee. Veterinary Cancer Society Newsletter Fall 1998.

5) High dose rate brachytherapy in the treatment of fibrosarcomas in cats. MC McEntee, GN Mauldin. Veterinary Cancer Society Newsletter Summer 1999.

6) Prognostic significance of histological grade and cytochemical staining patterns for

canine synovial cell sarcoma: preliminary results of a VCOG study. DM Vail, BE Powers, D Getzy, WB Morrison, MC McEntee, DA O'Keefe, AM Norris, SJ Withrow. Veterinary Cancer Society Newsletter, Spring 1993, volume 17, no. 1.

7) Current and future applications of radiation therapy in feline oncology – Part I. Feline Health Topics for Veterinarians, July-September 2000, volume 15, no 3.

8) Current and future applications of radiation therapy in feline oncology – Part II. Feline

Health Topics for Veterinarians, October-December 2000, volume 15, no 4. 9) Modern technology in radiation oncology. MC McEntee, DE Thrall. Veterinary Cancer

Society Newsletter, Winter 2000.

10) Radiographs from the 2000 Radiation Oncology Certifying Examination: Clinical Aspects of Radiation Oncology, Including Image Interpretation. MC McEntee. Vet Radiol & Ultrasound 2001;42(2):188-189.

11) When your dog has lumpy skin: distinguishing the benign from the malignant is key. Dog Watch Newsletter, Cornell University, College of Veterinary Medicine vol 6 no 3, March 2002, page 8.

12) Image from the 2001 Radiation Oncology Certifying Examination: Clinical Aspects of Radiation Oncology, Including Image Interpretation. MC McEntee. Vet Radiol & Ultrasound 2002;43(1):70.

13) Reproductive oncology. MC McEntee. Clinical Techniques in Small Animal Practice, 2002;17(3):133-149.

14) Principles and applications of radiation therapy. J Farrelly, MC McEntee. Clinical

Techniques in Small Animal Practice, 2003;18(2):82-87. 15) Vaccine-Associated Feline Sarcoma Task Force: Roundtable Discussion. The current

understanding and management of vaccine-associated sarcomas in cats. J Am Vet Med

Assoc 2005;226(11):1821-1842. 16) Orally administered docetaxel and cyclosporine for the treatment of canine tumors. MC McEntee. Vet Forum, in press 2007.

PRESENTATIONS

PROFESSIONAL CONTINUING EDUCATION

1) Veterinary Homecoming - NCSU-CVM Continuing Education Series, Clinical Oncology,

Fall 1988. 2) Pharmacokinetic and phase I toxicity evaluation of carboplatin in tumor-bearing dogs,

Veterinary Cancer Society 8th Annual Conference, October 1988.

3) A retrospective study of 27 dogs with intranasal neoplasms treated with radiation therapy, Veterinary Cancer Society 9th Annual Conference, October 1989. 4) Palliative radiotherapy in canine osteosarcoma, Veterinary Cancer Society 10th Annual


Conference, November 1990. 5) Effect of administered dose of a 2-nitroimidazole marker of hypoxia on ELISA and

immunohistochemical quantification of tumor binding, 41st Annual Meeting of the

Radiation Research Society and the 13th Annual Meeting of the North American Hyperthermia Society, March 1993.

6) Vaccination associated sarcomas in cats, Santa Cruz Veterinary Hospital CE seminar,

November 9, 1993. 7) Oncology update, Santa Cruz Veterinary Medical Association Meeting, January 11, 1994. 8) Infiltrative lipoma: results of irradiation in 9 dogs, Veterinary Cancer Society 14th

Annual Conference, October 1994. 9) Clinical oncology update, The Animal Medical Center Continuing Education Series, New

York, NY, February 1995.

10) Palliative radiotherapy in the management of canine and feline mammary gland tumors - 11 cases (1990-1994). 1995 Annual Meeting of the American College of Veterinary Radiology.

11) Radiation therapy in the management of cancer in companion animals. Continuing

Education Seminar New Jersey Veterinary Medical Association, February 1996. 12) Three-dimensional treatment planning in veterinary radiation oncology. Veterinary

Cancer Society 16th Annual Conference, October 1996.

13) Appropriate use of adjuvant radiotherapy. Sixth Annual American College Veterinary Surgery Symposium, November 1996.

14) Feline hyperthyroidism: medicine, surgery or radiation. Panel discussion. Sixth Annual

American College Veterinary Surgery Symposium, November 1996. 15) Multidisciplinary treatment of mast cell tumors. Sixth Annual American College

Veterinary Surgery Symposium, November 1996.

16) Multimodality therapy in veterinary oncology. Thirteenth Annual Veterinary Medical Forum. American College of Veterinary Internal Medicine, May 1998.

17) High dose rate brachytherapy in the treatment of vaccine associated sarcomas in cats.

Veterinary Cancer Society 1st Annual Mid-Year Meeting, Bodega Bay, February 4-7th, 1999.

18) Radiation therapy today: options available and case examples. Marin County Veterinary

Medical Association, July 27th, 1999. 19) Computed tomography of infiltrative lipomas in the dog: imaging results and utility in

radiation treatment planning. 1999 Annual Scientific Conference, American College of

veterinary Radiology, December 1-5. 20) Hemoclip position and utility in radiation treatment planning. A pilot study. 1999

Annual Scientific Conference, American College of Veterinary Radiology, December 1-

5. 21) The utility of imaging and initial diagnostics in treatment planning. Feline Vaccine

Associated Sarcoma Workshop. 1999 Annual Scientific Conference, American College

of Veterinary Radiology, December 1-5. 22) Feline Vaccine Associated Sarcomas. North Valley Veterinary Medical Association,

California, February 15th, 2000.

23) Strontium-90 in the treatment of cutaneous mast cell tumors. Veterinary Cancer Society 2nd Annual Mid-Year Meeting, Tucson, April 1, 2000.

24) Controversies in oncology: treatment of vaccine-associated sarcomas. Panel discussion.

18th Annual Veterinary Medical Forum. American College of Veterinary Internal Medicine, May, 2000.


25) Current and future applications of radiation therapy in feline oncology. 12th Annual Fred Scott Feline Symposium, Cornell University, Ithaca, New York, July 29, 2000.

26) Vaccine Associated Sarcoma: Management Update. 12th Annual Fred Scott Feline

Symposium, Cornell University, Ithaca, New York, July 29, 2000. 27) Feline vaccine-associated sarcoma. 20th Annual Conference of the Veterinary Cancer

Society. Technician Program. Pacific Grove, California, October 16th, 2000.

28) Fibrosarcomas in cats. New York State Association of Veterinary Technicians Fall Workshop 2000. Cornell University, Ithaca, New York, November 19, 2000.

29) The utility of contrast enhanced computed tomography in feline vaccine associated

sarcomas: 35 cases. 2000 Annual Scientific Conference, American College of Veterinary Radiology, December 2, 2000.

30) Vaccine-associated sarcomas: diagnosis and treatment strategies. 93rd Annual

Conference for Veterinarians. College of Veterinary Medicine, Cornell University, Ithaca, New York, March 23, 2001.

31) Tumor imaging: an oncologist’s perspective. 93rd Annual Conference for Veterinarians.

College of Veterinary Medicine, Cornell University, Ithaca, New York, March 23, 2001. 32) Mast cell tumors: a review and update. 93rd Annual Conference for Veterinarians.

College of Veterinary Medicine, Cornell University, Ithaca, New York, March 23, 2001.

33) Vaccine associated sarcomas: diagnostic and treatment strategies. 2001 Annual Conference, Washington State University, College of Veterinary Medicine, Pullman, Washington, April 6, 2001.

34) Canine and feline nasal tumors: review and update. 2001 Annual Conference, Washington State University, College of Veterinary Medicine, Pullman, Washington, April 6, 2001.

35) Tumor imaging: an oncologist’s perspective. 2001 Annual Conference, Washington State University, College of Veterinary Medicine, Pullman, Washington, April 6, 2001.

36) Veterinary radiation oncology today. 2001 Annual Conference, Washington State

University, College of Veterinary Medicine, Pullman, Washington, April 6, 2001. 37) Clinical case management. McEntee MC, Mealey K, Sellon R. 2001 Annual

Conference, Washington State University, College of Veterinary Medicine, Pullman,

Washington, April 6, 2001. 38) Canine mast cell tumors: review and update. 2001 Annual Conference, Washington State

University, College of Veterinary Medicine, Pullman, Washington, April 7, 2001.

39) Clinical case management. McEntee MC, Mealey K, Sellon R. 2001 Annual Conference, Washington State University, College of Veterinary Medicine, Pullman, Washington, April 7, 2001.

40) Radiation induced second tumor in dogs irradiated for oral acanthomatous epulis. 2001 Annual Scientific Conference of the American College of Veterinary Radiology, August 5-10, 2001.

41) Atlantic Coast Veterinary Conference, Atlantic City, New Jersey, October 9-11th, 2001. Seven hours of continuing education lectures given on a variety of oncology topics.

42) The Future of Radiation Therapy at Cornell University. 94th Annual Conference for

Veterinarians, College of Veterinary Medicine, Cornell University, Ithaca, NY. March 15th, 2002.

43) Veterinary radiation oncology I: current state of the art. 139th American Veterinary

Medical Association Convention, July 13, 2002. 44) Veterinary radiation oncology II: definitive vs palliative radiation – decision making

process. 139th American Veterinary Medical Association Convention, July 13, 2002.


45) Tumor staging: now that we found something what do we do about it? 139th American Veterinary Medical Association Convention, July 13, 2002.

46) Soft tissue sarcomas: an overview. 139th American Veterinary Medical Association

Convention, July 13, 2002. 47) Survey of radiation facilities in the United States in 2001; Presidential Address. 2002

Annual Scientific Conference of the American College of Veterinary Radiology,

December 3-7, 2002. 48) Radiation Therapy at Cornell University. Southern Tier Veterinary Medical Association,

January 30th, 2003.

49) Radiation Therapy: What You Need to Know. 96th Annual Cornell Veterinary Conference, March 26, 2004.

50) Veterinary Radiation Oncology round table discussion. Central New York Veterinary

Medical Association, Syracuse, NY May 10, 2004. 51) Mast Cell Tumors in Dogs and Cats: Now and in the Future. 141st American Veterinary

Medical Association Annual Convention July 25, 2004.

52) Radiation Therapy: What You and Your Clients Need to Know and What Your Expectations Should Be. 141st American Veterinary Medical Association Annual Convention July 25, 2004.

53) Radiation Oncology. Mast Cell Tumors in Dogs and Cats. Genesee Valley Veterinary Medical Association, September 23, 2004, 4 hour lecture.

54) Vaccine-Associated Feline Sarcoma Task Force Roundtable participant. Denver,

Colorado December 6th, 2004. 55) Radiation Therapy: Rethinking our approach. 97th Annual Cornell Veterinary

Conference, June 13th, 2005.

56) Vaccine-Associated Feline Sarcoma Task Force Roundtable participant – Panel Discussion: What do we know and what do we not know? (2) 1.5 hour sessions. 142nd American Veterinary Medical Association Annual Convention, Minneapolis, Minnesota,

July 17, 2005. 57) The effect of using hemoclips in conjunction with the surgical incision in determining

radiation treatment field size. 2005 Annual Scientific Conference of the American

College of Veterinary Radiology, Chicago, Ill., December 1-3, 2005. 58) Cancer Care in the Small Animal Patient: The Role of Palliative and Definitive Radiation

Therapy. Metropolitan New Jersey Veterinary Medical Association CE lecture (2 hours),

January 18th, 2006, Newark, NJ. 59) Veterinary Radiation Oncology. Central Florida Veterinary Radiology CE lecture (2

hours), February 7th, 2006, Maitland, FL.

60) The Role of Radiation Therapy in the Management of Canine and Feline Mast Cell Tumors CE Lecture (1 hour), March 24th, 2006, Danbury, CT.

61) Optimizing Radiation Oncology: Imaging Solutions to a Complex Problem. Dept. of

Clinical Sciences Seminar Series. Cornell University, Ithaca, NY. April 25th, 2006. 62) Docetaxel & Cyclosporine Combination Therapy for Canine Tumors. American College

of Veterinary Internal Medicine Forum, Specialist Session, Louisville, Kentucky, June

2nd, 2006. 63) Preoperative versus postoperative 3D radiation treatment planning for soft tissue tumors.

International Veterinary Radiology Association/American College Veterinary Radiology

Conference, Vancouver, Canada, August 10, 2006.


OTHER PRESENTATIONS

1) Veterinary Oncology. Ithaca NY Kennel Club, Cornell University, Ithaca, New York,

May 22, 2001. 2) Learning from our pets. 51st Annual Meeting of the Board of Trustees and the Cornell

University Council, October 20, 2001.

3) Evaluation of superficial masses: diagnostic and treatment considerations. Ithaca NY Kennel Club, Cornell University, Ithaca, New York, October 30, 2001.

4) Clinical Oncology at Cornell University. A Greyhound Celebration; Benefit for Canine

Cancer Research, September 22, 2002. 5) Cancer in Dogs and Cats. Positively Pets Cable TV show, Syracuse NY, live broadcast

June 20, 2003.

6) Cancer, Pets and People. A presentation on the Oncology Program at the College of Veterinary Medicine. Cornell Reunion 2004, Barton Hall, CVM Booth, June 12, 2004.

7) Cancer in Dogs. Presentation to invited guests at the 129th Annual Westminster Dog

Show, NYC, February 15, 2005. 8) Veterinary Oncology: An Introduction. Explorations in Veterinary Medicine Summer

Seminar Program. Cornell University, July 1, 2005.

9) Wine Country Circuit Dog Show, October 1, 2005, Sampson State Park, Romulus, New York. Cancer in dogs: if we can’t prevent it then we need to detect it early.

10) Cancer in Golden Retrievers. A presentation for the Long Island Golden Retriever Club,

Long Island, April 19, 2006. 11) Advances in Feline Cancer Management. Your Cat’s Health “The Latest News from

Cornell’s Feline Health Experts”. Presentation at Cornell Reunion, June 9, 2006.

12) Our Animals, Ourselves. Cancer presentation to invited guests. College of Veterinary Medicine, Cornell University, Ithaca, NY, October 6, 2006.

13) Practitioner’s Rounds at Cornell University, Oncology case topics, January 18, 2007.

14) Cancer presentation to invited guests. 131st Annual Westminster Dog Show, NYC, February 13, 2007.

PROFESSIONAL SERVICE

AMERICAN COLLEGE OF VETERINARY INTERNAL MEDICINE

1) ACVIM medical oncology examination committee – 1994 – 1997. Chairman – 1996 –

1997. 2) ACVIM medical oncology residency standards committee – 1998 - 2001. Chairman -

1999 - 2001.

3) ACVIM medical oncology residency program ad hoc committee to determine radiation therapy training requirements for medical oncology residency programs. Chairman – Summer 1998 - Spring 1999.

4) ACVIM Ad Hoc Committee on Residency Programs in Private Practice, 2000-2001. 5) ACVIM Constitution Committee, member, 2001 – 2004. 6) ACVIM Nominating Committee (Vice President, At-Large Members) – 2002.

AMERICAN COLLEGE OF VETERINARY RADIOLOGY


1) ACVR radiation oncology residency standards committee – 1995 - 2000. 2) ACVR radiation oncology affiliate examination committee, member - 1996 - 2001. Co-

chair of the examination committee 1999 - 2000, chair 2000 - 2001.

3) ACVR radiation oncology affiliate examination committee, secretary - 1998 - 2001. 4) ACVR radiation oncology affiliate, President-elect - March 1999 - December 2000. 5) ACVR radiation oncology affiliate - program coordinator for the radiation oncology

session at the annual ACVR meeting 1999 - 2000. 6) ACVR radiation oncology affiliate, President – December 2000 – 2002. 7) ACVR veterinary specialty of radiation oncology, Past President – December 2002 –

2004. 8) ACVR radiation oncology examination committee – November 2003 – 2006. Co-chair

for the 2005 Certifying Examination. Chair of the 2006 Certifying Examination.

9) ACVR Constitution Committee – December 2005 – present. VETERINARY CANCER SOCIETY

1) VCS Executive Committee, member at large - 1996 - 1998. Guest editor VCS newsletter

Fall 1996, Fall 1997, Fall 1998.

UNIVERSITY COMMITTEES

1) University of California, Davis. Academic Senate Undergraduate Scholarships, Honors, and Prizes Committee - September 1, 1999 - August 31, 2000.

2) University of California, Davis. Strauss Foundation Scholarship Subcommittee –

November 16, 1999 - August 31, 2000. 3) Cornell University; Faculty Senate representative for the Department of Clinical Sciences

– July 1, 2006 – present (3 year term).

COLLEGE COMMITTEES

1) Cornell University; Residency Program Committee, March 2001 – 2006. Chair 2000-

2006.

2) Cornell University Affirmative Action Committee, member – October 2002 – present. 3) Cornell University – search committee for endocrinologist, affirmative action

representative – October 2002 – December 2003.

4) Cornell University, Dept. of Population Medicine and Diagnostic Sciences – search committee for two clinical pathologists – January 2003 – October 2003.

5) Cornell University, Baker Institute – search committee for two faculty members in cancer

biology – July 2003. Search committee suspended. 6) Cornell University, Dept. of Molecular Medicine – search committee for two faculty

members in cell and molecular biology – October 2004 – April 2005.

7) Cornell University, Baker Institute – search committee for two faculty members in comparative mammalian genomics – December 2004 – June 2005.

8) Cornell University, Dept. of Molecular Medicine – search committee for one faculty

member in cell and molecular biology – September 2005 – April 2006.


9) Cornell University, Biomedical Sciences – search committee for two faculty members in diagnostic pathology, one tenure track/one non-tenure track – July 2005 – 2006. Search continued for one faculty member in diagnostic pathology – September 2006 – July 2007.

10) Cornell University, Population Medicine and Diagnostic Sciences – search committee for a Shelter Medicine Clinician – October 2005 – April 2006.

11) Cornell University, Population Medicine and Diagnostic Sciences – search committee for

a Clinical Pathologist, tenure track – June 2006 – August 2006. 12) Cornell University, Dept. of Molecular Medicine – search committee for one faculty

member in cell and molecular biology – September 2006 – September 2007.

13) Cornell Feline Health Center Strategic Planning Committee – committee to evaluate the future direction of the feline health center – August 2007 – December 2007.

14) Cornell University, Biomedical Sciences – search committee for one faculty member in

diagnostic pathology – September 2007 – present. 15) Cornell University Veterinary College Admissions Committee Reader – September 2007

for class entering in 2008.

16) Biomedical Sciences Strategic Planning Committee – member, January 2008 – present.

DEPARTMENT COMMITTEES

1) University of California, Academic Planning Committee – Animal Health: Companion

Animal – November 1998 – 1999. 2) University of California, Department of Surgical & Radiological Sciences, Search

committee for soft tissue surgery faculty position – 1998.

3) University of California, Department of Surgical & Radiological Sciences, Search committee for medical oncology faculty position – November1998 - 1999.

4) University of California, Department of Surgical & Radiological Sciences, Search

committee for surgical oncology faculty position - March 1999 - February 2000. 5) Cornell University, Dept. of Clinical Sciences – search committee for small animal

internal medicine clinical position – November 2000 – 2001.

6) Cornell University, Dept. of Clinical Sciences – search committee for small animal surgery non-tenure track position – November 2001-2002.

7) Cornell University, Dept. of Clinical Sciences – search committee for clinical radiologist

– February 2002 – 2003. Inactive. Re-activated December 2004 – December 2005. 8) Cornell University, Dept. of Clinical Sciences Family Leave Policy Committee, member

– July 2004 - 2005.

9) Cornell University, Dept. of Clinical Sciences – search committee for a dentist, non-tenure track – August 2005 – November 2005.

10) Cornell University, Dept. of Clinical Sciences – search committee for a medical

oncologist, non-tenure track – December 2005 – April 2006. 11) Cornell University, Dept. of Clinical Sciences – search committee for small animal

internal medicine tenure track position – March 2006 – June 2006.

12) Cornell University, Dept. of Clinical Sciences – search committee for cardiology tenure track position – May 2006 – October 2006.

13) Cornell University, Dept. of Clinical Sciences – search committee for lecturer in internal

medicine – January 2007 – present.


HOSPITAL COMMITTEES

1) CCAH planning committee for the UCDavis Cancer Center – 1997-1998.

2) University of California, Davis. Staffing Clinical Programs - A Strategy for the 21st Century. Committee member, November 1999 – May 2000.

3) University of California, Davis Veterinary Medical Teaching Hospital - committee to

develop a proposal for a year round senior clinic; and address specialty clinic requirements, January 2000 – February 2000.

4) Cornell University, CUHA, Digital Users Group Committee, member – August 2004 -

2005. 5) Cornell University Hospital for Animals Planning Committee, member – October 2007 –

present.

OTHER ACTIVITIES

1) Cornell Pet Loss Support Hotline – Faculty Advisor, 2007-2008.

2) Cancer Video targeted toward pet owners– provided concept and have participated

in production, 2007. Funded through a donation to the Feline Health Center.


BIOGRAPHICAL SKETCH

Provide the following information for the key personnel in the order listed for Form Page 2.

Follow this format for each person. DO NOT EXCEED FOUR PAGES.

NAME POSITION TITLE

Margret Sara Thompson Lecturer, Section of Imaging

EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)

INSTITUTION AND LOCATION DEGREE

(if applicable) YEAR(s) FIELD OF STUDY

Smith College, Northampton, MA A.B. 1985-89 Architecture

Boston University, Boston, MA M. Ed. 1992-93 Counseling Psychology

Tufts University, N. Grafton, MA D.V.M. 1994-98 Veterinary Medicine

Angell Memorial Animal Hospital, Boston, MA Internship 1998-99 Rotating Internship

University of Florida, Gainesville, FL Residency 1999-2002 Veterinary Radiology Section A and B should not exceed two pages: A. Positions and Honors Positions and Employment:

2006-current Lecturer, Cornell University, College of Veterinary Medicine, Ithaca, NY

2002-2006 Clinical Assistant Professor, University of Florida, College of Veterinary Medicine, Gainesville, FL

Other Experience and Professional Memberships:

American College of Veterinary Radiology- board certified in radiology (2002)

American Veterinary Medical Association B. Selected peer-reviewed publications

1) Scrivani PS, Thompson MS, Weingarder KR, Dewey CW, Scarlett JM. Association between

frontal-sinus size and syringohydromyelia in small-breed dogs. Am J Vet Res. 2007 Jun;68(6):610-3.

2)Adin CA, Sereda CW, Thompson MS, Wheeler JL, Archer LL. Use of a percutaneously controlled hydraulic occluder in the treatment of canine intrahepatic shunts: short-term outcome

in 10 dogs. J Am Vet Med Assoc. 229(11):1749-55, 2006.

3) Marolf A, Specht A, Castleman W, Thompson MS. Radiographic and Urethrographic Findings associated with a Penile Hemangiosarcoma. Vet Radiol Ultrasound. 47(5) 474-475, 2006.

4) MacInnes TJ, Thompson MS, Lewis DD. What is your diagnosis? Benign Bone Cysts. J Am Vet Med Assoc 227(10):1561-2, 2005. 5)Farese JP, Milner R, Thompson MS, et al. Stereotactic radiosurgery for the treatment of

osteosarcomas involving the distal portions of the limbs in dogs. J Am Vet Med Assoc 225(10): 1572-87, 2005. 6)Guille AE, Lewis DD, Anderson TP, Beaver DP, Carrera-Justiz SC, Thompson MS, et al.

Evaluation of surgical repair of humeral condylar fractures using self-compressing Orthofix pins in 23 dogs. Vet Surg 33(4):314-22, 2004. 7)Williams LS, Levy JK, Thompson MS. What is your diagnosis? Canine Pulmonary

Lymphoma. J Am Vet Med Assoc 224, 2004. 8)Gunkel CI, Valverde A, Robertson SA, Thompson MS, et al. Treatment for a severe reaction


to intravenous administration of diatrizoate in an anesthetized horse. J Am Vet Med Assoc 224(7):1143-6, 2004. 9) Williams LS, Levy JK, Thompson MS. What is your diagnosis – Lymphoma of High Grade

Malignancy. J Am Vet Med Assoc 224 (2):205-206, 2004. 10) Eino D, Citino S, Thompson MS. Clinical Challenge. Journal of Zoo and Wildlife Medicine 34(4):416, 2004.

11) Thompson MS, Graham JP, Mariani CL. Helical CT Angiography: Diagnosis of a Porto-Azygous Shunt. Vet Radiol Ultrasound 44(3):287-291, 2003. 12) Shilton CM, Thompson MS, et al. Nasopharyngeal myxosarcoma in a Bengal tiger

(Panthera tigris). Journal-of-Zoo-and-Wildlife-Medicine 33(4):371-377, 2002. 13) Thompson MS, Graham JP, Miyabayashi T. What is Your Diagnosis? Bilateral Osteosarcoma in a Great Dane. J Am Vet Med Assoc 219(7): 911-912, 2001.

14) Dhar AK, Thompson MS, et al. Determination of cDNA Sequence and mRNA Expression of Interleukin 1 Receptor Antagonist in Horses. Am J Vet Res 67(8):920-4, 2000. C. Research Support Current Support: N/A Pending Support: ACVR Resident Research Grant (Ultrasound Society) - $5000


Dennis Burt Bailey Jr., DVM

Diplomate, ACVIM (Oncology)

C3 501C Clinical Programs Center (607) 253-3434 (phone)

College of Veterinary Medicine (607) 253-3055 (fax)

Cornell University [email protected]

Ithaca, NY 14853

Education and Training:

Residency in Medical Oncology, Cornell University. July 2001 – July 2004.

Internship in Small Animal Medicine and Surgery, N.C. State University. June 2000 – June 2001. Doctor of Veterinary Medicine, with distinction, Cornell University. May 2000. Bachelor of Science (General Biology), with distinction, Cornell University. May 1997.

Board Certification:

Diplomate, American College of Veterinary Internal Medicine (Oncology). 2004.

Professional Licensure:

New York State. License number 008564. Active licensure since June 2000.

Current Positions:

Lecturer in Medical Oncology, Cornell University. August 2006 – present.

Veterinary Information Network (VIN). On-line consultant. March 2007 – present.

Memberships in Professional Organizations:

American College of Veterinary Internal Medicine Veterinary Cancer Society Veterinary Cooperative Oncology Group

American Veterinary Medical Association Phi Zeta, the National Veterinary Honor Society Gamma Sigma Delta, Honor Society of Agriculture

Teaching Responsibilities:

VTMed 752 – Advanced Clinical Oncology. Lecturer. 2007, 2008

VTMed 708 – Clinical Oncology (clinical hospital rotation with 2-4 students per 2-week block) Assisted senior veterinary students with the development of diagnostic and therapeutic plans for cancer patients, conducted teaching rounds. 2001-2004, 2006-present.

VTMed 517 – Animals, Veterinarians, and Society (Part A). Assisted with student laboratories. 2007.

VTMed 537 – Animals, Veterinarians, and Society (Part C). Assisted with student laboratories.

2007. VTMed 666 – Veterinary Clinical Oncology. Lecturer. 2002, 2003, 2008 VTMed 523 – Fourth-Year Seminar. Advisor. 2001-2003, 2007

VTMed 520 – Genetics and Development. Lecturer. 2001-2003, 2006, 2007 ACVIM Board Preparation Lecture Series. Lecturer. 2007. Intern Continuing Education Lecture Series. Lecturer. 2007, 2008


National Boards Review Class. Conducted review sessions for senior veterinary students preparing for the NAVLE. 2001-2003, 2006, 2007.

Administrative Responsibilities:

ACVIM Medical Oncology Certifying Examination Committee. 2007 – present. Internship committee, Long Island Veterinary Specialists. Helped restructure the program to

include more interns and improve teaching opportunities, interviewed and ranked prospective candidates, advised and guided interns to help them transition into independently thinking veterinarians, counseled interns regarding future career plans. July 2004 – present.

Interim head of the internship committee, Long Island Veterinary Specialists. In addition to above responsibilities, acted as the primary liaison between the interns and the remainder of the hospital staff. July 2005 – October 2005.

Internship selection committee, Cornell University College of Veterinary Medicine. Member, 2002, 2003.

Member of the House Officer Panel for the comprehensive accreditation review performed by the

Council on Education of the American Veterinary Medical Association for the Cornell University College of Veterinary Medicine, 2003.

Scientific Reviewing

Veterinary Medicine, 2007 – present Journal of the American Veterinary Medical Association, 2007 – present

Publications in Peer-Reviewed Journals:

1. Flory A, Rassnick K, Al-Sarraf R, Bailey D, Balkman C, Kiselow M, Autio K. Combination

of CCNU and DTIC Chemotherapy for Treatment of Resistant Lymphoma in Dogs. J Vet Intern Med. In press.

2. McEntee MC, Rassnick KM, Bailey DB, Balkman CB, Zgola MM, Page RL. Phase I

evaluation of oral docetaxel and cyclosporine A in tumor-bearing cats. J Vet Intern Med 2006;20:1370-1375.

3. Bailey DB, Rassnick KM, Erb HN, Dykes NL, Hoopes PJ, Page RL. Effect of glomerular

filtration rate on carboplatin clearance and myelotoxicity in tumor-bearing cats. Am J Vet Res 2004;11:1502-1507.

4. Bailey D, Erb H, Williams L, Ruslander D, Hauck M. Carboplatin and doxorubicin

combination chemotherapy for the treatment of appendicular osteosarcoma in the dog. J Vet Intern Med 2003;17:199-205.

5. Schneider H, Baro DJ, Bailey D, Canter G, Harris-Warrick RM, Kravitz EA. Patterns of

Shaker family gene expression in single identified neurons of the American lobster, Homarus

americans. Receptors and Channels 2000;7:53-64. 6. Bagrodia S, Bailey D, Lenard Z, Hart M, Guan JL, Premont R, Taylor SJ, and Cerione RA. A

tyrosine-phosphorylated protein that binds to an important regulatory region on the cool family of p21-activated kinase-binding proteins. J Biol Chem 1999;274:22393-22400.


RADIATION BIOLOGY Topics to be covered

Radiation chemistry

Cellular responses to DNA damage

Survival curves

Sublethal damage repair, potentially lethal damage repair

Linear energy transfer

Relative biological effectiveness

Radiation-induced cell cycle effects and age response through the cell cycle

Mutagenesis, transformation and carcinogenesis

The oxygen effect and reoxygenation

Radiosensitizers, and radioprotectors

Normal and tumor cell kinetics

Early and late effects

4 R’s of radiotherapy

Radiation and chemotherapy interactions

Dose rate and dose fractionation effects

Hyperthermia

Miscellaneous topics


RADIATION PHYSICS Topics to be covered

Atomic and nuclear structure

Radioactive decay

Properties and production of particulate and electromagnetic radiation

Interactions of electromagnetic radiation with matter

Interactions of particulate radiation with matter

Quantification and measurement of dose

Characteristics of photon beams

Dosimetry of photon beams in a homogenous water phantom

Dosimetry of photon beams in a patient

Dosimetry of electron beams

Brachytherapy

Radiation protection

Other topics


Sanjay Raina, PhD in Medical Physics, Assistant Professor of Radiation Oncology Physics We have a contract with Roswell Park Cancer Institute in Buffalo and have access to all of the

physicists but our primary contact is with Sanjay Raina who works in Ithaca at the Cayuga Medical Center and provides physics support. Class work provided for trainees at Roswell Park is available for residents. Additionally, patient chart rounds are an option for radiation residents

at Cornell at Cayuga Medical which are done once a week using a teleconference facility with the personnel at Roswell Park in Buffalo.


Radiation Oncology Resident Evaluation

Cornell University

Resident Name ______________________________

Evaluator(s) _________________________________________

Period covered by this evaluation ________________________

Year of program : 1 2

CATEGORY 1 2 3 4 NA

CLINICAL ABILITY

Knowledge (theory/principle, current literature)

Application of knowledge, logic

Quality of patient management (diagnosis, treatment, follow-up)

Patient care

Diagnostic/technical skills

Instructional skill

Oral and written presentation

Other

SENSE OF RESPONSIBILITY

Initiative, motivation

Judgement

Reliability

Organization

Attendance at rounds and seminars

Punctuality

Other

INTERPERSONAL SKILLS

Communication with :

Clients

Faculty

Students

Technical and administrative staff

Referring veterinarians

Other house officers

Performance under stress

Receptiveness toward guidance

Other

HOSPITAL POLICIES AND PROCEDURES

Medical records, including reports (timeliness, accuracy, completeness)

Procedures (anesthesia scheduling, admissions/discharge)

Other

STUDENT EVALUATION OF PERFORMANCE

PROGRESS ON RESIDENCY AND BOARD REQUIREMENTS

OVERALL EVALUATION

1 – frequently exceeds expectations/standards

2 – fully achieves expectations/standards

3 – needs improvement

4 – fails to achieve expectations/standards

NA = not applicable


Residents are expected to achieve a “fully achieves expectations/standards” in each category. For categories with a

“frequently exceeds standards” score, residents should be acknowledged and commended. Suggestions for

improvement with a reasonable time frame should be addressed for categories with a “needs improvement” or “fails

to achieve expectations/standards” score. There should be evidence of improvement at the time of the next

evaluation. If an overall score of “fails to achieve expectations/standards” is given at any time, a review of the

resident is required to determine whether the resident will continue in his/her program.

Written comments by faculty:

Written summary of student evaluations:

I have read and understand this evaluation.

Signed,

Resident ______________________________________

Advisor _______________________________________

Date __________________________________________

revised 12/07 american college of veterinary radiology

Documents

training program directors

actual training program

support of program

alternative program

program requirement

acvrroresidency program

essential program faculty

approved standard program